The Thyroid Hormone Receptor-β-Selective Agonist GC-1 Differentially Affects Plasma Lipids and Cardiac Activity.
The Thyroid Hormone Receptor-β-Selective Agonist GC-1 Differentially Affects Plasma Lipids and Cardiac Activity.
复制标题
DOI:
10.1210/endo.141.9.7681
复制
发表时间:
2000-09
期刊:
影响因子:
4.8
通讯作者:
S. Trost;E. Swanson;B. Gloss;D. B. Wang-Iverson;Hongjiang Zhang;T. Volodarsky;Gary J Grover;
中科院分区:
文献类型:
--
作者:
S. Trost;E. Swanson;B. Gloss;D. B. Wang-Iverson;Hongjiang Zhang;T. Volodarsky;Gary J Grover;
Thyroid hormones influence the function of many organs and mediate their diverse actions through two types of thyroid hormone receptors, TRα and TRβ. Little is known about effects of ligands that preferentially interact with the two different TR subtypes. In the current study the comparison of the effects of the novel synthetic TRβ-selective compound GC-1 with T3 at equimolar doses in hypothyroid mice revealed that GC-1 had better triglyceride-lowering and similar cholesterol-lowering effects than T3. T3, but not GC-1, increased heart rate and elevated messenger RNA levels coding for the If channel (HCN2), a cardiac pacemaker that was decreased in hypothyroid mice. T3 had a larger positive inotropic effect than GC-1. T3, but not GC-1, normalized heart and body weights and messenger RNAs of myosin heavy chain α and β and the sarcoplasmic reticulum adenosine triphosphatase (Serca2). Additional dose-response studies in hypercholesteremic rats confirmed the preferential effect of GC-1 on TRβ-mediated paramete...